BRPI0816513A2 - Composição farmacêutica e método para preparar a suspensão sólida - Google Patents
Composição farmacêutica e método para preparar a suspensão sólidaInfo
- Publication number
- BRPI0816513A2 BRPI0816513A2 BRPI0816513A BRPI0816513A2 BR PI0816513 A2 BRPI0816513 A2 BR PI0816513A2 BR PI0816513 A BRPI0816513 A BR PI0816513A BR PI0816513 A2 BRPI0816513 A2 BR PI0816513A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- pharmaceutical composition
- solid suspension
- suspension
- solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98118507P | 2007-10-19 | 2007-10-19 | |
| US3894308P | 2008-03-24 | 2008-03-24 | |
| PCT/US2008/080327 WO2009052391A1 (en) | 2007-10-19 | 2008-10-17 | Solid formulations of crystalline compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0816513A2 true BRPI0816513A2 (pt) | 2015-03-24 |
Family
ID=40567797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0816513 BRPI0816513A2 (pt) | 2007-10-19 | 2008-10-17 | Composição farmacêutica e método para preparar a suspensão sólida |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20100222311A1 (pt) |
| EP (1) | EP2214635A1 (pt) |
| JP (1) | JP2011500724A (pt) |
| CN (1) | CN101896161A (pt) |
| AU (1) | AU2008312321A1 (pt) |
| BR (1) | BRPI0816513A2 (pt) |
| CA (1) | CA2702935A1 (pt) |
| IL (1) | IL205130A0 (pt) |
| MX (1) | MX2010004222A (pt) |
| WO (1) | WO2009052391A1 (pt) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
| AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
| EP2600877A4 (en) | 2010-08-04 | 2014-05-07 | Borody Thomas J | COMPOSITIONS FOR DARMFLORA TRANSPLANTATION AND METHOD FOR THE PRODUCTION AND USE THEREOF, AND METHOD FOR THEIR ADMINISTRATION |
| DK2651415T3 (da) | 2010-12-13 | 2020-11-30 | Rite Prep Pty Ltd | Mave- og tyktarmsformuleringer og fremgangsmåder til fremstilling og brug af dem |
| BR112013021030A2 (pt) * | 2011-02-17 | 2016-10-11 | Hoffmann La Roche | processo para cristalização controlada de um ingrediente farmacêutico ativo a partir de estado líquido super-refrigerado por extrusão por fusão a quente |
| EP3135291A1 (en) | 2011-03-09 | 2017-03-01 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
| US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
| CN104540521A (zh) | 2012-06-04 | 2015-04-22 | 高拉夫·阿格拉沃尔 | 用于治疗克罗恩氏病和相关病况以及感染的组合物和方法 |
| KR102152873B1 (ko) | 2012-07-27 | 2020-09-08 | 레드힐 바이오파마 엘티디 | 결장 배출의 용도를 위한 제형 및 제형의 제조 방법 |
| US20160089363A1 (en) | 2013-04-30 | 2016-03-31 | Thomas Julius Borody | Compositions and methods for treating microbiota-related psychotropic conditions and diseases |
| US11045401B2 (en) | 2013-07-24 | 2021-06-29 | Heartland Consumer Products Llc | Partial melt co-crystallization compositions |
| US11839698B2 (en) | 2014-03-13 | 2023-12-12 | W. L. Gore & Associates, Inc. | Drug composition and coating |
| MX381237B (es) | 2015-03-03 | 2025-03-12 | Heartland Consumer Products Llc | Composiciones edulcorantes que contienen rebaudiósidos d. |
| JP6692897B2 (ja) | 2015-05-14 | 2020-05-13 | クレストヴォ・ホールディングス・エルエルシー | 便フローラを移植するための組成物、並びにそれを調製及び使用する方法、並びにそれを送達するためのデバイス |
| ES2909456T3 (es) | 2015-05-22 | 2022-05-06 | Univ Arizona State | Métodos para tratar el trastorno del espectro autista y síntomas asociados |
| US10561766B2 (en) | 2015-09-15 | 2020-02-18 | W. L. Gore & Associates, Inc. | Drug composition and coating |
| US11214773B2 (en) | 2015-09-24 | 2022-01-04 | San Diego State University (Sdsu) Foundation | Antibacterial and protective bacteriophage formulations and methods for making and using them |
| US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
| US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
| US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
| US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
| WO2018071536A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating primary sclerosing cholangitis and related disorders |
| AU2018250206A1 (en) | 2017-04-05 | 2019-10-31 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (PD) and related disorders |
| WO2018187464A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
| AU2018272048B2 (en) | 2017-05-26 | 2024-04-04 | Finch Therapeutics Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
| CN110621305A (zh) | 2017-07-24 | 2019-12-27 | 爱科思华制药研发有限责任公司 | 高载药量药物组合物 |
| CN111328284A (zh) | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于维持和恢复健康的肠道屏障的组合物和方法 |
| EP3511001B1 (en) * | 2018-01-12 | 2021-09-22 | Alfred E. Tiefenbacher (GmbH & Co. KG) | Pirfenidone-containing tablet and capsule formulation |
| US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
| CN113164527A (zh) | 2018-09-27 | 2021-07-23 | 芬奇治疗控股有限责任公司 | 用于治疗癫痫和相关障碍的组合物和方法 |
| EP3866923A1 (en) * | 2018-10-17 | 2021-08-25 | Sandoz AG | Co-crystals comprising levothyroxine and a dicarboxylic acid |
| WO2020210205A1 (en) * | 2019-04-08 | 2020-10-15 | Cosci Med-Tech Co., Ltd | Methods of improving pharmaceutical substance solubilization and products thereof |
| CN115944654A (zh) | 2019-07-19 | 2023-04-11 | 芬奇治疗控股有限责任公司 | 用于治疗胃肠道病症的方法及产品 |
| CN116033891A (zh) * | 2020-09-03 | 2023-04-28 | 菲利普莫里斯生产公司 | 冷冻干燥的低吸湿性活性粉末组合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4310543A (en) * | 1980-10-09 | 1982-01-12 | Hoffmann-La Roche Inc. | Prostaglandin compositions |
| US4525339A (en) * | 1982-10-15 | 1985-06-25 | Hoffmann-La Roche Inc. | Enteric coated oral dosage form |
| US4476248A (en) * | 1983-02-28 | 1984-10-09 | The Upjohn Company | Crystallization of ibuprofen |
| US4892742A (en) * | 1985-11-18 | 1990-01-09 | Hoffmann-La Roche Inc. | Controlled release compositions with zero order release |
| US5190748A (en) * | 1988-11-22 | 1993-03-02 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US5075291A (en) * | 1989-11-22 | 1991-12-24 | Ici Americas Inc. | Crystalline sugar alcohol containing uniformly dispersed particulate pharmaceutical compound |
| HUT59653A (en) * | 1990-11-15 | 1992-06-29 | Puetter Medice Chem Pharm | Process for producing complexes containing s/+/-phenyl-alcanoic acids and alpha-hydroxy-alcanoic acids and pharmaceutical compositions containing them as active components |
| US5318781A (en) * | 1993-04-06 | 1994-06-07 | Hoffmann-La Roche Inc. | Absorption enhancement of antibiotics |
| US5393765A (en) * | 1993-12-13 | 1995-02-28 | Hoffmann-La Roche Inc. | Pharmaceutical compositions with constant erosion volume for zero order controlled release |
| US6008228A (en) * | 1995-06-06 | 1999-12-28 | Hoffman-La Roche Inc. | Pharmaceutical compositions containing proteinase inhibitors |
| US6350786B1 (en) * | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6482847B2 (en) * | 2000-10-03 | 2002-11-19 | Hoffmann-La Roche Inc. | Amorphous form of cell cycle inhibitor having improved solubility and bioavailability |
| EP1390063B1 (en) * | 2001-05-03 | 2004-11-17 | F. Hoffmann-La Roche Ag | Pharmaceutical dosage form of amorphous nelfinavir mesylate |
| BRPI0407181A (pt) * | 2003-02-03 | 2006-02-07 | Novartis Ag | Formulação farmacêutica |
| RU2343905C2 (ru) * | 2003-10-10 | 2009-01-20 | Лайфсайкл Фарма А/С | Твердые дозированные формы, включающие фибрат и статин |
| WO2005105102A1 (en) * | 2004-05-04 | 2005-11-10 | Equitech Corporation | Improved nsaid composition |
-
2008
- 2008-10-17 WO PCT/US2008/080327 patent/WO2009052391A1/en not_active Ceased
- 2008-10-17 EP EP08839405A patent/EP2214635A1/en not_active Withdrawn
- 2008-10-17 CA CA2702935A patent/CA2702935A1/en not_active Abandoned
- 2008-10-17 AU AU2008312321A patent/AU2008312321A1/en not_active Abandoned
- 2008-10-17 JP JP2010530145A patent/JP2011500724A/ja not_active Withdrawn
- 2008-10-17 MX MX2010004222A patent/MX2010004222A/es not_active Application Discontinuation
- 2008-10-17 CN CN2008801202412A patent/CN101896161A/zh active Pending
- 2008-10-17 BR BRPI0816513 patent/BRPI0816513A2/pt not_active IP Right Cessation
- 2008-10-17 US US12/682,938 patent/US20100222311A1/en not_active Abandoned
-
2010
- 2010-04-15 IL IL205130A patent/IL205130A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009052391A1 (en) | 2009-04-23 |
| AU2008312321A1 (en) | 2009-04-23 |
| EP2214635A1 (en) | 2010-08-11 |
| JP2011500724A (ja) | 2011-01-06 |
| CA2702935A1 (en) | 2009-04-23 |
| IL205130A0 (en) | 2010-11-30 |
| CN101896161A (zh) | 2010-11-24 |
| US20100222311A1 (en) | 2010-09-02 |
| MX2010004222A (es) | 2010-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0816513A2 (pt) | Composição farmacêutica e método para preparar a suspensão sólida | |
| BRPI0815138A2 (pt) | Métodos e organismos para a produção acoplada a crescimento de 1,4-butanodiol | |
| BRPI0818430A2 (pt) | Composição antiperspirante sólida e método para a produção da mesma | |
| BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
| BRPI0912384A2 (pt) | composição, e, método para preparar uma composição | |
| BRPI0814153A2 (pt) | "método para preparar um composto e composto" | |
| BRPI0919199A2 (pt) | suspensões farmacêuticas submicrométricas estabilizadas e métodos para preparas as mesmas | |
| BRPI0817727A2 (pt) | composição de graxa lubrificante, e, método para preparar uma composição de graxa | |
| GB2456752B (en) | Agrochemical composition and method for preparing the same | |
| BRPI0909691A2 (pt) | Composto, método para preparar um composto, e, composição farmacêutica | |
| BRPI0813774B8 (pt) | produto microencapsulado, método para preparar o mesmo, e, produto consumível | |
| BRPI0814611A2 (pt) | Composição, processo para preparar uma composição, e, uso de uma composição | |
| BRPI0819020A2 (pt) | "método e sistema para criar uma peça" | |
| FI20075533L (fi) | Hiomatuote ja menetelmä tämän valmistamiseksi | |
| DK2140867T4 (da) | Farmaceutisk sammensætning | |
| BRPI0919466A2 (pt) | composição farmacêutica para liberação modificada | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0914918A2 (pt) | forma de dosagem farmacêutica, e, método para preparar uma forma de dosagem sólida. | |
| BR112012002102A2 (pt) | composição farmaceutica e metodo para preparar uma composição farmaceutica | |
| BRPI0812647A2 (pt) | "composição e método para produzir a composição" | |
| BRPI0807220B1 (pt) | composição, e, métodos para aumentar a força de compressão de uma composição e para aumentar a retenção de fragrância de uma composição | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0818483A2 (pt) | Método para preparar uma composição farmacêutica, composição farmacêutica, e, uso da mesma. | |
| BRPI0720530A2 (pt) | Partícula, processo para preparar a partícular, e, composição | |
| BRPI0720705A2 (pt) | Método para preparar uma composição de espumação, e, composição de espumação |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |